title: Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada.
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada. mdl@queensu.ca
authors.forename: M Diane
authors.initials: MD
authors.lastname: Lougheed
authors.forename: Catherine
authors.initials: C
authors.lastname: Lemiere
authors.forename: Sharon
authors.initials: S
authors.lastname: Dell
authors.forename: Francine
authors.initials: F
authors.lastname: Ducharme
authors.forename: J Mark
authors.initials: JM
authors.lastname: Fitzgerald
authors.forename: Richard
authors.initials: R
authors.lastname: Leigh
authors.forename: Chris
authors.initials: C
authors.lastname: Licskai
authors.forename: Brian H
authors.initials: BH
authors.lastname: Rowe
authors.forename: Dennis
authors.initials: D
authors.lastname: Bowie
authors.forename: Allan
authors.initials: A
authors.lastname: Becker
authors.forename: Louis-Philippe
authors.initials: LP
authors.lastname: Boulet
mesh_terms: D000293:Adolescent; D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D001249:Asthma / Q000188:drug therapy*; D002170:Canada; D002648:Child; D003692:Delayed-Action Preparations; D006801:Humans; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D003692:Delayed-Action Preparations